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Prazosin, 100 pg/kg, had no effect on baseline refractoriness or intraventricular conduction in anesthetized dogs. 
During 1 h of coronary artery occlusion followed by reperfusion, prazosin significantly blunted the shortening of the 
ventricular effective refractory periods within ischemic myocardial region relative to vehicle-treated animals. Prazosin 
treatment also prevented the delayed conduction of paced ventricular complexes entering and exiting the ischemic 
zone. These effects may be associated with the blockade of a,-adrenoceptor activation during the acute phase of 
myocardial ischemia. 
Myocardial ischemia Reperfusion a,-Adrenoceptor 
1. Introduction 
The early phase of acute coronary artery occlu- 
sion is accompanied by progressive conduction 
delay and alterations in ventricular refractoriness 
within the ischemic zone. These evolving abnor- 
malities precede, and critically influence, the sub- 
sequent appearance of ventricular fibrillation (VF) 
(Russell and Oliver, 1978; Fujimoto et al., 1981; 
Elharrar and Zipes, 1982). 
Recent data suggest that a,-adrenoceptor 
stimulation of the ischemic myocardium may play 
an important role in mediating these electrophysi- 
ologic events. While the effects of a,-adrenoceptor 
stimulation appear to be minor under most physi- 
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ologic conditions, increases in a,-adrenoceptor 
density specific to the ischemic zone have been 
demonstrated early after coronary occlusion (Corr 
et al., 1981). Prazosin, a specific a,-adrenoceptor 
antagonist, has been reported to have an antifibril- 
latory effect during coronary artery occlusion and 
reperfusion in anesthetized cats (Sheridan et al., 
1980) and dogs (Benfey et al., 1984). We examined 
the influence of prazosin on alterations in conduc- 
tion and refractoriness during acute ischemia and 
subsequent reperfusion in an anesthetized canine 
model. 
2. Materials and methods 
2.1. Surgical preparation 
Male mongrel dogs, 12-17 kg, were anesthetized 
with 0.7 ml/kg of Dial-urethane solution, in- 
cubated and ventilated on room air. Left common 
carotid and left external jugular cannulas were 
inserted for the monitoring of arterial pressure 
and the administration of drugs. The heart was 
exposed, and two diagonal branches of the left 
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anterior descending coronary artery were isolated 
2-3 mm from their origins. Polyurethane ligatures 
were placed loosely around each vessel. All visible 
collaterals to both vessels were ligated. Two sets of 
quadripolar plunge electrodes (Teflon coated 30 
gauge silver wire with distal 1 mm tip exposed, 2 
mm separation between each pole) were inserted 
at a depth of 4-5 mm, one each into the center of 
the zone to be made ischemic (IZ), and into the 
normal myocardium (NZ) 3 cm from the IZ. One 
bipole in each zone was connected to a Grass S88 
stimulator through a constant current stimulus 
isolation unit for the introduction of extrastimuli. 
Outputs from the second bipole in each zone were 
filtered at 50-500 Hz and displayed on a storage 
oscilloscope simultaneously with the lead II surface 
electrocardiogram. The sinus node was crushed, 
and atria1 pacing was performed at a constant 
cycle length of 400 ms throughout the study. 
2.2. Measurement techniques 
Excitation thresholds were determined in each 
zone by the introduction of extrastimuli (4 ms 
pulse width) of progressively increasing intensity 
(0.01 mA increments) every sixth beat at a con- 
stant coupling interval of 300 ms. The effective 
refractory period (to the nearest 1 ms) of each 
zone was determined by the extrastimulus tech- 
nique, using a stimulus intensity of twice local 
diastolic threshold. Brief ventricular pacing at a 
cycle length of 300 ms from each zone was per- 
formed. Conduction time was measured from the 
stimulus artifact recorded in the paced zone to the 
first rapid deflection of the bipolar electrogram 
recorded in the distant zone. Determinations from 
the 10th to 15th paced beat were averaged and 
expressed as entrance conduction (time to local 
activation of IZ from pacing in NZ) and exit 
conduction time (time to local activation of NZ 
from pacing in IZ). 
2.3. Experimental design 
After pretreatment recordings, animals were 
randomized to receive 100 pg/kg of intravenous 
(i.v.) prazosin, or an equivalent volume of vehicle. 
In preliminary experiments, this dose of prazosin 
produced near maximal inhibition of the pressor 
response to a,-adrenoceptor stimuli (10 pg/kg i.v. 
phenylephrine, and the electrical stimulation of 
distal thoracic sympathetic chain). 
Thirty minutes after treatment, electrophysio- 
logic measurements were repeated. Both diagonal 
arteries then were occluded for 1 h, followed by 1 
h of reperfusion. Serial determinations of excita- 
tion thresholds, refractoriness and conduction were 
made in each zone at 10 min intervals. Ventricular 
extrastimuli were delivered at twice the excitation 
threshold determined for the particular time and 
zone of stimulation. At the end of the experiment 
both vessels were re-occluded. Four milliliters of 
fluoroscein dye was injected rapidly into the left 
atrium, and the heart was fibrillated by high inten- 
sity electrical stimulation. The heart was removed 
and sectioned transversely into 5 mm slices and 
examined under ultraviolet light. The sharply de- 
lineated area of absent fluorescence, correspond- 
ing to the hypoperfused zone, was quantitated 
gravimetrically and expressed as a percentage of 
the total left ventricular mass. 
2.4. Statistical analysis 
Data are expressed as means + S.E. Changes in 
each electrophysiologic variable were examined 
using a factorial analysis of variance incorporating 
treatment, zone of measurement, and time from 
onset of occlusion. To minimize the influence of 
baseline variability between animals, baseline de- 
terminations were included in the analysis as a 
covariate (ANCOVA). 
3. Results 
Pretreatment excitation thresholds, refractory 
periods and conduction times were similar in 
animals treated with prazosin, 100 pg/kg (n = 5) 
and those treated with vehicle (n = 5). No signifi- 
cant changes in these variables were observed 
after treatment with either prazosin or vehicle 
before coronary artery occlusion. 
In vehicle-treated animals, the IZ refractory 
period shortened by 30% within the first 30 min of 
coronary artery occlusion, followed by a slight 
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prolongation, despite persisting ischemia (fig. 1A). 
After reperfusion, there was a progressive 
lengthening of the IZ refractory period (from 130 
to 226 ms), to values that exceeded baseline de- 
terminations. In contrast, pretreatment with 
prazosin blunted the initial post occlusion shorten- 
ing of the IZ refractory period (mean 9% decrease), 
and attenuated the overshoot prolongation of re- 
fractoriness during reperfusion (fig. 1B). In both 
treatment groups, NZ refractory periods did not 
vary from the baseline values during the periods 
of occlusion and reperfusion. The influence of 
treatment on alterations in ischemic zone refracto- 
riness over time was highly significant (P < 0.0001, 
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Fig. 1. Alterations in ventricular refractoriness during coronary 
artery occlusion and reperfusion in vehicle-treated (A), and 
prazosin-treated (B) anesthetized dogs. The effective refractory 
period in ms is represented on the abscissa. For this and the 
following figure, numbers on the ordinate represent time in 
mm post occlusion and reperfusion respectively. B, baseline; 
PV, 30 mm post vehicle administration; PD, 30 mm post 
prazosin administration. 
ANCOVA). Excitation thresholds in the ischemic 
zone of vehicle-treated animals tended to increase 
over time during both occlusion and reperfusion, 
but the observed change was not statistically sig- 
nificant (P = 0.37, ANCOVA). 
Both entrance and exit conduction times of 
paced ventricular complexes lengthened after 
coronary artery occlusion (fig. 2). Significantly 
greater conduction delay in both directions de- 
veloped in vehicle-treated animals compared to 
those treated with prazosin (P = 0.02, ANCOVA). 
Conduction velocity tended to improve toward 
baseline values after reperfusion. 
There was a slight decline in the mean arterial 
pressure after treatment with prazosin (from 108 
+ 4 to 101 + 6 mm Hg), but there were no signifi- 
cant differences between the two treatment groups 
at any point during the study. Two vehicle-treated 
animals developed VF during the study, at 35 min 
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Fig. 2. Alterations in conduction times of paced ventricular 
complexes entering (A) and exiting (B) the ischemic zone 
during coronary artery occlusion and reperfusion. Conduction 
time in ms is represented on the abscissa. PT, 30 min post 
treatment. 
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post occlusion and at 21 min of reperfusion, re- 
spectively. These animals were defibrillated im- 
mediately. None of the prazosin-treated animals 
developed VF. Appropriate positioning of all elec- 
trodes was confirmed at postmortem examination. 
Hypoperfused zone size was similar between 
vehicle-treated (9.5 k 0.8% left ventricular mass) 
and prazosin-treated (10.6 + 1.0% left ventricular 
mass) animals. 
4. Discussion 
In this study, coronary artery occlusion in un- 
treated animals was followed by a shortening of 
the effective refractory period in the ischemic 
myocardium and a progressive delay in the con- 
duction time of paced ventricular complexes enter- 
ing and exiting the ischemic zone. These observa- 
tions agree with those of previous investigators 
using similar techniques (Russell and Oliver, 1978; 
Fujimoto et al., 1981; Elharrar and Zipes, 1982). 
Pretreatment with prazosin significantly blunted 
these evolving electrophysiologic changes during 
acute ischemia and, in addition, abolished the 
excessive prolongation in the ischemic zone refrac- 
toriness upon reperfusion. The effects of prazosin 
were specific for the ischemic myocardium. Re- 
fractoriness in normal myocardium as well as the 
conduction time of paced ventricular complexes 
were not influenced by prazosin. 
In normal superfused rabbit Purkinje fiber and 
papillary muscle preparations, a,-adrenoceptor 
stimulation has been shown to prolong the action 
potential duration (Dukes and Vaughan Williams, 
1984a). In similar preparations, prazosin also pro- 
longs the action potential duration and, in ad- 
dition, depresses maximal upstroke velocity in a 
dose-dependent manner (Dukes and Vaughan Wil- 
liams, 1984b). These observations challenge the 
role of a,-adrenoceptor stimulation in producing 
the electrophysiologic abnormalities accompany- 
ing acute ischemia, and suggest that the protective 
effect of prazosin may be mediated by direct 
electrophysiologic actions. 
However, it is uncertain that observations in 
isolated superfused non-ischemic tissues pertain to 
conditions during myocardial ischemia. In guinea- 
pig isolated hearts depleted of catecholamines, 
there was a blunting of the shortening of the 
action potential duration and effective refractory 
period during global myocardial ischemia, and a 
reduced incidence of VF during both coronary 
occlusion and reperfusion (Sheridan and Culling, 
1985). These effects were mimicked by both the 
non-specific a-receptor antagonist, phentolamine, 
and the a,-adrenoceptor antagonist, indoramin. 
The addition of phentolamine to catecholamine- 
depleted hearts had no further influence on the 
action potential duration or refractoriness. The 
addition of the a,-adrenoceptor agonist, methox- 
amine, to catecholamine-depleted hearts reversed 
the protective effects of catecholamine depletion. 
These findings suggest that ischemia-related shor- 
tening of ventricular refractoriness is mediated at 
least in part by a,-adrenoceptor activation, and 
that the attenuation of the electrophysiologic con- 
sequences of ischemia by the a,-adrenoceptor 
antagonist is mediated via adrenergic rather than 
direct myocardial electrophysiologic effects, As in 
the present study, the addition of a,-adrenoceptor 
antagonists to non-ischemic, non-catecholamine- 
depleted preparations resulted in relatively slight 
electrophysiologic changes (Sheridan and Culling, 
1985). The apparent conflict in the results regard- 
ing the direct electrophysiologic actions of prazo- 
sin between the in vitro assessments of Dukes and 
Vaughan Williams (1984b) and the present in vivo 
study may be due to many factors. Empirically, 
assessment of the electrophysiologic actions of 
prazosin in isolated tissue preparations provides 
the most controlled determination of direct drug 
action, while the in vivo assessment in the present 
report constitutes a determination of direct drug 
action as well as the influence of potential reflex 
actions. Alternatively, the results of Sheridan and 
Culling (1985) and those of the present studies 
may reflect the ability of prazosin to attenuate 
electrophysiologic changes that evolve during acute 
ischemic injury in the heart at concentrations be- 
low that required to produce direct electrophysio- 
logic actions in non-ischemic tissue. 
During the early phases of acute myocardial 
ischemia, tissue catecholamine release with intense 
adrenergic stimulation of ischemic myocardium 
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has been proposed to play an important role in 
the genesis of abnormal cellular electrical activity 
and ultimately arrhythmias (Riemersma, 1982). 
The present in vivo findings, in conjunction with 
the in vitro data of Sheridan and Culling (1985) 
indicate that the emergence of serious conduction 
delays and alterations in refractoriness within 
acutely ischemic myocardium are mediated, at least 
in part, by cY,-adrenoceptor activation. An at- 
tenuation of such electrophysiologic aberrations 
by a,-adrenoceptor antagonists such as prazosin 
may be responsible for the observed antifibrilla- 
tory effects of this class of drugs during coronary 
artery occlusion and reperfusion. 
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